LANSDOWNE PARTNERS (UK) LLP filings

Add to watchlist

This page lists the SEC filings reported by LANSDOWNE PARTNERS (UK) LLP.

All
Holdings
Significant ownership
Insider transactions
Events
Shareholder votes
SEC filings by LANSDOWNE PARTNERS (UK) LLP (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G2024-02-13LANSDOWNE PARTNERS (UK) LLPSoho House & Co Inc.2,619,1414.9%EDGAR
SC 13G2023-02-08LANSDOWNE PARTNERS (UK) LLPMembership Collective Group Inc.2,841,7745.1%EDGAR
SC 13G2022-02-14LANSDOWNE PARTNERS (UK) LLPSupernova Partners Acquisition Co II, Ltd.2,152,9116.2%EDGAR
SC 13D/A2020-06-17LANSDOWNE PARTNERS (UK) LLPSummit Therapeutics plc13,664,8804.1%EDGAR
SC 13D/A2020-05-15LANSDOWNE PARTNERS (UK) LLPSummit Therapeutics plc17,670,9155.3%EDGAR
SC 13D/A2020-03-26LANSDOWNE PARTNERS (UK) LLPSummit Therapeutics plc21,143,5006.3%EDGAR
SC 13G/A2020-02-14LANSDOWNE PARTNERS (UK) LLPManchester United plc00.0%EDGAR
SC 13G/A2019-02-13LANSDOWNE PARTNERS (UK) LLPManchester United plc2,228,3555.5%EDGAR
SC 13D/A2019-01-11LANSDOWNE PARTNERS (UK) LLPSummit Therapeutics plc21,143,50013.2%EDGAR
SC 13G/A2018-10-03LANSDOWNE PARTNERS (UK) LLPManchester United plc2,679,3156.7%EDGAR
SC 13D/A2018-01-30LANSDOWNE PARTNERS (UK) LLPSummit Therapeutics plc19,060,50025.9%EDGAR
SC 13G/A2018-01-30LANSDOWNE PARTNERS (UK) LLPCYTOKINETICS INC2,647,9814.9%EDGAR
SC 13D/A2017-09-20LANSDOWNE PARTNERS (UK) LLPSummit Therapeutics plc19,060,50027.1%EDGAR
SC 13G/A2016-02-12LANSDOWNE PARTNERS (UK) LLPCYTOKINETICS INC2,848,1817.2%EDGAR
SC 13G/A2016-02-12LANSDOWNE PARTNERS (UK) LLPRESPONSE GENETICS INC00.0%EDGAR
SC 13G/A2016-01-08LANSDOWNE PARTNERS (UK) LLPManchester United plc4,941,44012.4%EDGAR
SC 13D/A2015-03-26LANSDOWNE PARTNERS (UK) LLPSummit Therapeutics plc15,727,17025.8%EDGAR
SC 13D2015-03-16LANSDOWNE PARTNERS (UK) LLPSummit Therapeutics plc15,727,17027.0%EDGAR
SC 13G/A2015-02-17LANSDOWNE PARTNERS (UK) LLPManchester United plc3,931,4459.9%EDGAR
SC 13G/A2014-08-14LANSDOWNE PARTNERS (UK) LLPManchester United plc3,731,4459.4%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.